Electrophysiological and neuroimaging evaluation of C9ORF72 related Amyotrophic lateral sclerosis

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Amyotrophic lateral sclerosis (also known as Motor Neuron Disease) is a rapid and fatal neurological condition. To date there is no consensus on where the disease process may start. We will study healthy carriers who carry the most common ALS gene mutation and follow them over a four year period and track the associated changes. We will be using specialized neurophysiological tests to evaluate these patients and we hope to localize where the initiating problem with ALS patients may start.

Funded Activity Details

Start Date: 01-01-2016

End Date: 01-01-2019

Funding Scheme: Early Career Fellowships

Funding Amount: $224,786.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Neurology and Neuromuscular Diseases

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

amyotrophic lateral sclerosis | biomarkers | cortical excitability | neurophysiology | transcranial magnetic stimulation (TMS)